Gunn & Company Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.13M Sell
9,718
-103,962
-91% -$34M 2.15% 20
2024
Q2
$35.5M Buy
113,680
+104,075
+1,084% +$30.6M 2.11% 22
2024
Q1
$2.73M Sell
9,605
-99,233
-91% -$29M 2.05% 21
2023
Q4
$31.3M Buy
108,838
+99,688
+1,089% +$27.2M 2.07% 26
2023
Q3
$2.46M Buy
+9,150
New +$2.28M 2.16% 20

Other funds holding AMGN

Gunn & Company Investment Management's AMGN Position: Q3 2024 in Review

Gunn & Company Investment Management reduced its Amgen (AMGN) stake by 91% in Q3 2024, selling an estimated $34M and leaving 9,718 shares worth $3.13M. The position accounts for 2.15% of the portfolio, ranked #20.

Gunn & Company Investment Management first reported a position in AMGN in Q3 2023 and has held it in 5 quarters since. The position peaked at $35.5M in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Gunn & Company Investment Management held 9,718 shares of Amgen worth $3.13M as of Q3 2024.
  • Gunn & Company Investment Management sold 103,962 Amgen shares in Q3 2024, an estimated $34M.
  • Amgen made up 2.15% of Gunn & Company Investment Management's portfolio in Q3 2024, its #20 holding.
  • Gunn & Company Investment Management first reported a position in Amgen in Q3 2023 and has held it in 5 quarters since.
  • Gunn & Company Investment Management's Amgen position peaked at $35.5M in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Gunn & Company Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.